Neurocrine lays off 100 employees

By Elaine Rigoli

Tampa, Fla., Aug. 8 - Neurocrine Biosciences, Inc. said it is eliminating about 100 employees at its San Diego campus as part of its restructuring program to prioritize its research and development programs.

Neurocrine said it expects to incur expenses of about $3.6 million related to this staff reduction during the third quarter of 2006, consisting of one-time termination benefits that include salary continuation, outplacement services and other benefit costs paid out in cash.

Neurocrine is a San Diego-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.